BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 21478088)

  • 1. Benign familial hypocalciuric hypercalcemia.
    Varghese J; Rich T; Jimenez C
    Endocr Pract; 2011; 17 Suppl 1():13-7. PubMed ID: 21478088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Familial hypocalciuric hypercalcemia and calcium sensing receptor.
    Mrgan M; Nielsen S; Brixen K
    Acta Clin Croat; 2014 Jun; 53(2):220-5. PubMed ID: 25163238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary hyperparathyroidism and familial hypocalciuric hypercalcemia: relationships and clinical implications.
    Eldeiry LS; Ruan DT; Brown EM; Gaglia JL; Garber JR
    Endocr Pract; 2012; 18(3):412-7. PubMed ID: 22232026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucocorticoid-responsive lymphocytic parathyroiditis and hypocalciuric hypercalcemia due to autoantibodies against the calcium-sensing receptor: a case report and literature review.
    Song L; Liu L; Miller RT; Yan SX; Jackson N; Holt SA; Maalouf NM
    Eur J Endocrinol; 2017 Jul; 177(1):K1-K6. PubMed ID: 28515208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Case Report: Severe Neonatal Course in Paternally Derived Familial Hypocalciuric Hypercalcemia.
    Höppner J; Lais S; Roll C; Wegener-Panzer A; Wieczorek D; Högler W; Grasemann C
    Front Endocrinol (Lausanne); 2021; 12():700612. PubMed ID: 34659108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Familial benign hypocalciuric hypercalcemia.
    Fuleihan Gel-H
    J Bone Miner Res; 2002 Nov; 17 Suppl 2():N51-6. PubMed ID: 12412778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neonatal severe hyperparathyroidism, secondary hyperparathyroidism, and familial hypocalciuric hypercalcemia: multiple different phenotypes associated with an inactivating Alu insertion mutation of the calcium-sensing receptor gene.
    Cole DE; Janicic N; Salisbury SR; Hendy GN
    Am J Med Genet; 1997 Aug; 71(2):202-10. PubMed ID: 9217223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Familial hypocalciuric hypercalcemia. Mild expression of the gene in heterozygotes and severe expression in homozygotes.
    Marx SJ; Fraser D; Rapoport A
    Am J Med; 1985 Jan; 78(1):15-22. PubMed ID: 3966479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutations of the calcium-sensing receptor (CASR) in familial hypocalciuric hypercalcemia, neonatal severe hyperparathyroidism, and autosomal dominant hypocalcemia.
    Hendy GN; D'Souza-Li L; Yang B; Canaff L; Cole DE
    Hum Mutat; 2000 Oct; 16(4):281-96. PubMed ID: 11013439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Familial Hypocalciuric Hypercalcemia as an Atypical Form of Primary Hyperparathyroidism.
    Marx SJ
    J Bone Miner Res; 2018 Jan; 33(1):27-31. PubMed ID: 29115694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel germline inactivating mutation in the CASR gene in an Italian kindred affected by familial hypocalciuric hypercalcemia.
    Falchetti A; Gozzini A; Terranegra A; Soldati L; Vezzoli G; Leoncini G; Giusti F; Franceschelli F; Masi L; Tanini A; Cavalli L; Brandi ML
    Eur J Endocrinol; 2012 May; 166(5):933-40. PubMed ID: 22315359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Familial hypocalciuric hypercalcemia in an index male: grey zones of the differential diagnosis from primary hyperparathyroidism in a 13-year clinical follow up.
    Zajíčková K; Dvořáková M; Moravcová J; Včelák J; Goltzman D
    Physiol Res; 2020 Sep; 69(Suppl 2):S321-S328. PubMed ID: 33094630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New mutation in the CASR gene in a family with familial hypocalciuric hypercalcemia (FHH) and neonatal severe hyperparathyroidism (NSHPT).
    Rodrigues LS; Cáu AC; Bussmann LZ; Bastida G; Brunetto OH; Corrêa PH; Martin RM
    Arq Bras Endocrinol Metabol; 2011 Feb; 55(1):67-71. PubMed ID: 21468522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Familial hypercalciuric hypercalcemia].
    Kassem M; Eriksen EF; Mosekilde L
    Nord Med; 1991; 106(4):107-8, 111. PubMed ID: 2038554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Novel Missense
    Bletsis P; Metzger R; Nelson JA; Gasparini J; Alsayed M; Milas M
    AACE Clin Case Rep; 2022; 8(5):194-198. PubMed ID: 36189134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Familial hypocalciuric hypercalcemia: recognition among patients referred after unsuccessful parathyroid exploration.
    Marx SJ; Stock JL; Attie MF; Downs RW; Gardner DG; Brown EM; Spiegel AM; Doppman JL; Brennan MF
    Ann Intern Med; 1980 Mar; 92(3):351-6. PubMed ID: 7356229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is routine 24-hour urine calcium measurement useful during the evaluation of primary hyperparathyroidism?
    Li SR; McCoy KL; Levitt HE; Kelley ML; Carty SE; Yip L
    Surgery; 2022 Jan; 171(1):17-22. PubMed ID: 34325903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parathyroidectomy in familial hypercalcemia with clinical characteristics of primary hyperparathyroidism and familial hypocalciuric hypercalcemia.
    Szabo E; Hellman P; Lundgren E; Carling T; Rastad J
    Surgery; 2002 Mar; 131(3):257-63. PubMed ID: 11894029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism caused by inactivating mutations of calcium-sensing receptor].
    Watanabe S; Fukumoto S
    Nihon Rinsho; 2002 Feb; 60(2):325-30. PubMed ID: 11857921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An association between neonatal severe primary hyperparathyroidism and familial hypocalciuric hypercalcemia in three kindreds.
    Marx SJ; Attie MF; Spiegel AM; Levine MA; Lasker RD; Fox M
    N Engl J Med; 1982 Feb; 306(5):257-64. PubMed ID: 7054696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.